ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209 | +22.2% | 9 | -75.0% | 0.00% | – |
| Q2 2023 | $171 | -12.8% | 36 | +44.0% | 0.00% | -100.0% |
| Q1 2023 | $196 | +7.7% | 25 | -39.0% | 0.01% | +500.0% |
| Q4 2022 | $182 | -99.9% | 41 | -86.2% | 0.00% | -88.9% |
| Q3 2022 | $256,000 | -5.9% | 297 | -29.3% | 0.01% | +12.5% |
| Q2 2022 | $272,000 | -23.6% | 420 | -23.9% | 0.01% | -20.0% |
| Q1 2022 | $356,000 | -31.4% | 552 | -35.7% | 0.01% | -16.7% |
| Q4 2021 | $519,000 | +737.1% | 858 | +10625.0% | 0.01% | -58.6% |
| Q3 2021 | $62,000 | +313.3% | 8 | -98.5% | 0.03% | +123.1% |
| Q3 2019 | $15,000 | – | 527 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |